基本信息
浏览量:93
职业迁徙
个人简介
Dr. Rokach has received worldwide recognition for the first syntheses of major inflammatory mediators such as leukotrienes and lipoxins that are responsible for diseases such as allergies of the lung and nose (asthma, rhinitis) and play a major role in diseases such as inflammatory bowel diseases. The availability of these synthetic mediators has opened the field to medical research in the areas of allergy and inflammation. Dr. Rokach and his team have designed selective drugs in this area that are now on the market as prescription drug for asthma (Singulair). In recognition of his scientific achievements, Dr. Rokach has been awarded several prizes and honors, including the Government of Canada Silver Award (1986); Prix Urgel Archambault (1986); Canadian Society for Chemistry, John Labatt Ltd. Award (1988); Xerox Lecturer (1988); Chinese Academy of Science (Taiwan) Award (1988); and the Paul Ehrlich Prize (Paris, France) (1990).
In addition to his research activities, Dr. Rokach serves on various international advisory committees and on the editorial boards of several scientific journals. He is the author of 226 refereed publications, 40 reviews, 56 patents, and the author and editor of the book Leukotrienes and Lipoxygenases.
研究兴趣
论文共 453 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
IUPHAR/BPS guide to pharmacology CITEno. 1 (2023)
Shishir Chourey,Rui Wang,Qiuji Ye,Chintam Nagendra Reddy,Shiyu Sun, Norito Takenaka,William S Powell,Joshua Rokach
Chemical & pharmaceutical bulletinno. 7 (2023): 534-544
引用0浏览0WOS引用
0
0
IUPHAR/BPS Guide to Pharmacology CITEno. 3 (2020)
IUPHAR/BPS guide to pharmacology CITEno. 4 (2019)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn